I'rom Group Co (2372.T) Stock Price

The business model of I'rom Group Co Ltd involves providing comprehensive healthcare services in Japan. The company operates through various segments, including Clinical Testing Business, Home Care Business, and Healthcare Support Business. I'rom Group offers clinical testing and diagnostic services, supplies medical equipment, and provides home healthcare services. They collaborate with medical institutions, pharmaceutical companies, and insurance companies to ensure high-quality care and support for patients. By offering a range of healthcare services, I'rom Group aims to improve medical accessibility and contribute to the well-being of individuals in Japan.

I'rom Group Co Ltd is primarily active in the healthcare industry and provides a wide range of medical services and solutions. The company operates and manages medical facilities, provides clinical trial support, and offers healthcare information technology systems. With a focus on patient care and healthcare innovation, I'rom Group Co Ltd plays a significant role in improving the overall healthcare ecosystem.

The main competitors of I'rom Group Co Ltd in the market include companies such as Medical Excellence JAPAN Co Ltd, HOYA Corporation, TERUMO CORPORATION, and Nipro Corporation.

I'rom Group Co Ltd is a company based in Japan that specializes in providing pharmaceutical and healthcare solutions. Established in 2002, I'rom Group Co Ltd has grown to become a leader in the healthcare industry, offering a range of services including clinical research, medical device distribution, and home care support. The company has built a strong reputation for its commitment to innovation and quality, catering to both domestic and international markets. With a strong focus on advancing healthcare solutions, I'rom Group Co Ltd continues to make significant contributions to the industry, further solidifying its position as a trusted and reliable provider in the market.

I'rom Group Co Ltd is primarily present in Japan.

The values and corporate philosophy of I'rom Group Co Ltd revolve around three core principles. Firstly, they prioritize the health and well-being of patients by providing high-quality medical services and advanced pharmaceutical products. Secondly, they emphasize social contribution through active engagement in research and development, as well as collaborations with medical institutions. Lastly, I'rom Group Co Ltd values integrity and professionalism in their business practices, striving for transparency and accountability. With a commitment to innovation and customer-centricity, I'rom Group Co Ltd aims to improve healthcare standards and effectively meet the diverse needs of their stakeholders.

Converted at the current exchange rate, the I'rom Group Co share trades at 15.76 EUR (2,790.00 JPY).

The I'rom Group Co share (2372.T) is listed on 1 stock exchanges, including: Tokio (JPX) (2372.T).

The company I'rom Group Co Ltd is an innovative Japanese company that has been offering a wide range of health products and services since its founding in 2007. The company is headquartered in Osaka, Japan and operates branches and partner companies worldwide. The I'rom Group is divided into various business sectors, including Healthcare, Pharma, IT, and e-Commerce. In each of these sectors, the company offers a wide range of products and services tailored to the specific needs and requirements of its customers. The Healthcare sector is an important business sector for the company. Here, the company offers a wide range of products and services, including medical care, health consultation and management, diagnosis and treatment plans, as well as rehabilitation and nursing care. The company works closely with medical facilities and health organizations to ensure that their customers receive the best care and support. The Pharma sector is another important business sector for the company. Here, they offer a wide range of drugs and medications, including generics and prescription medications. The focus is on the development of medications for a variety of diseases and ailments, including cancer, cardiovascular diseases, neurological disorders, and infectious diseases. The I'rom Group takes pride in supporting their customers with high-quality products and solutions that help improve their lives and maintain their health. In the IT sector, the company offers innovative technologies and solutions aimed at improving healthcare and medical care. This includes e-health solutions, telemedicine, mobile apps, and software solutions for medical diagnosis and assessment. The company works closely with leading technology companies and research institutions to ensure that their customers always have access to the latest innovations and advances. The e-Commerce sector is the company's newest business sector, aiming to offer a wider range of health products and services online. Here, the company offers a wide range of products, including dietary supplements, medical devices, beauty products, and health services. The focus is on making the online shopping process as easy and convenient as possible to ensure that customers can enjoy the best experience and highest level of convenience. Overall, I'rom Group Co Ltd is a company dedicated to healthcare and improving the health of its customers. With innovative products, services, and technologies, the company aims to play a leading role in the healthcare industry and provide its customers with a comprehensive solution for their well-being and health.

The expected revenue of I'rom Group Co is 15.76 B JPY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of I'rom Group Co is 2.32 B JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of I'rom Group Co is currently 14.53. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the I'rom Group Co stock.

The price-to-sales ratio (P/S) of I'rom Group Co is currently 2.14. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the I'rom Group Co stock.

The Eulerpool Quality Score for I'rom Group Co is 3/10.

The ISIN of I'rom Group Co is JP3105170009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of I'rom Group Co is 2372.T. The ticker symbol is used to trade I'rom Group Co shares on the stock exchange.